Maintenance of proliferative capacity and retroviral transduction efficiency of human fetal CD38-/CD34++ stem cells

Stem Cells and Development

Volumn 15, Issue 1, 2006, Pages 97-108

  Muench, Marcus O ^a,c   Ohkubo, Tatsuo ^a   Smith, Clayton A ^b   Suskind, David L ^a   Bárcena, Alicia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; BLOOD DISEASE; CELL ISOLATION; CELL PROLIFERATION; CENTRIFUGATION; CLONOGENIC ASSAY; CONTROLLED STUDY; ENZYME DEFICIENCY; FETUS; FETUS CELL; GENE THERAPY; GESTATIONAL AGE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; MOLONEY LEUKEMIA ONCOVIRUS VECTOR; PLACENTA; PRIORITY JOURNAL; RETROVIRUS VECTOR; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; ANTIGENS, CD34; ANTIGENS, CD38; CELL PROLIFERATION; CYTOKINES; FETAL BLOOD; FETUS; HEMATOPOIETIC STEM CELLS; HEPATOCYTES; HUMANS; RETROVIRIDAE; THROMBOPOIETIN; TRANSDUCTION, GENETIC;

MOLONEY MURINE LEUKEMIA VIRUS;

EID: 33645380368     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.15.97     Document Type: Article

References (64)

1. Bui TH, E Blennow and M Nordenskjold. (2002). Prenatal diagnosis: molecular genetics and cytogenetics. Best Pract Res Clin Obstet Gynaecol 16:629-643.
2. Yang EY, AW Flake and NS Adzick. (1999). Prospects for fetal gene therapy. Semin Perinatol 23:524-534.
3. Porada CD, N Tran, M Eglitis, RC Moen, L Troutman, AW Flake, Y Zhao, WF Anderson and ED Zanjani. (1998). In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum Gene Ther 9:1571-1585.
4. Porada CD, PJ Park, G Almeida-Porada, W Liu, F Ozturk, HA Glimp and ED Zanjani. (2005). Gestational age of recipient determines pattern and level of transgene expression following in utero retroviral gene transfer. Mol Ther 11:284-293.
5. Thilaganathan B, KH Nicolaides and G Morgan. (1994). Subpopulations of CD34-positive haemopoietic progenitors in fetal blood. Br J Haematol 87:634-636.
6. Migliaccio G, M Baiocchi, N Hamel, K Eddleman and AR Migliaccio. (1996). Circulating progenitor cells in human ontogenesis: response to growth factors and replating potential. J Hematother 5:161-170.
7. Campagnoli C, N Fisk, T Overton, P Bennett, T Watts and I Roberts. (2000). Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood 95:1967-1972.
8. + hematopoietic stem/progenitor cells in fetal cord blood. Am J Obstet Gynecol 178: 931-937.
9. Gallacher L, B Murdoch, D Wu, F Karanu, F Fellows and M Bhatia. (2000). Identification of novel circulating human embryonic blood stem cells. Blood 96:1740-1747.
10. Jin CH, H Takada, A Nomura, Y Takahata, H Nakayama, M Kajiwara, H Nakano and T Kara. (2000). Immunophenotypic and functional characterization of CD33(+)CD34(+) cells in human cord blood of preterm neonates. Exp Hematol 28:1174-1180.
11. Jordan CT, G Yamasaki and D Minamoto. (1996). High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol 24:1347-1355.
12. Moore MAS, MO Muench, DJ Warren and J Laver. (1990). Cytokine networks involved in the regulation of haemopoietic stem cell proliferation and differentiation. In: Molecular Control of Haemopoiesis. John Wiley & Sons, Chichester, pp. 43-58.
13. Muench MO, M-G Roncarolo, R Namikawa, A Bárcena and MAS Moore. (1994). Progress in the ex vivo expansion of hematopoietic progenitors. Leuk Lymph 16:1-11.
14. Lansdorp PM, W Dragowska and H Mayani. (1993). Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787-791.
15. + human fetal liver progenitors with a high proliferative potential. Blood 83:3170-3181.
16. McNiece IK, FM Stewart, DM Deacon, DS Temeles, KM Zsebo, SC Clark and PJ Quesenberry. (1989). Detection of a human CFC with high proliferative potential. Blood 74:609-612.
17. Smith C, C Gasparetto, N Collins, A Gillio, MO Muench, RJ O'Reilly and MAS Moore. (1991). Purification and partial characterization of a human hematopoietic precursor population. Blood 77:2122-2128.
18. + human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp Hematol 26:1034-1042.
19. - cells in cord blood and bone marrow. Blood 86:3745-3753.
20. - cells and maintains progenitor cells in vitro. Blood 87:3563-3570.
21. Muench MO, MG Roncarolo, S Menon, Y Xu, R Kastelein, S Zurawski, CH Hannum, J Culpepper, F Lee and R Namikawa. (1995). FLK-2/FLT-3 ligand (FL) regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood 85:963-972.
22. Humeau L, C Chabannon, MT Firpo, P Mannoni, C Bagnis, M-G Roncarolo and R Namikawa. (1997). Successful reconstitution of human hematopoiesis in the SCID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver. Blood 90:3496-3506.
23. ++ cells: Implications for in utero and ex utero gene therapy. Fetal Diagn Ther 16:299-307.
24. Kobayashi M, J Laver, T Kalo and M Ogawa. (1996). Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88:429-436.
25. - primitive progenitors. Blood 88:1619-1631.
26. Kuter DJ and CG Begley. (2002). Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 100:3457-3469.
27. Heike T and T Nakahata. (2002). Ex vivo expansion of hematopoietic stem cells by cytokines. Biochim Biophys Acta 1592:313-321.
28. Muench MO and A Bárcena. (2004). Megakaryocyte growth and development factor is a potent growth factor for primitive hematopoietic progenitors in the human fetus. Pediatr Res 55:1050-1056.
29. Muench MO, DL Suskind and A Bárcena. (2002). Isolation, growth and identification of colony-forming cells with erythroid, myeloid, dendritic cell and NK-cell potential from human fetal liver. Biol Proced Online 4:10-23.
30. Muench MO, MG Roncarolo and R Namikawa. (1997). Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. Blood 89:1364-1375.
31. +/++ cells for transplantation. Bone Marrow Transplant 24:451-461.
32. Bradley TR and GS Hodgson. (1979). Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood 54:1446-1450.
33. Muench MO, JG Schneider and MAS Moore. (1992). Interactions among colony-stimulating factors, IL-1β, IL-6 and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol 20:339-349.
34. Moore MAS and DJ Warren. (1987). Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc Natl Acad Sci USA 84:7134-7138.
35. + T lymphocytes. Gene Ther 3:695-705.
36. McCowage GB, KL Phillips, TL Gentry, S Hull, J Kurtzberg, E Gilboa and C Smith. (1998). Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells. Exp Hematol 26:288-298.
37. Muench MO, L Humeau, B Paek, T Ohkubo, LL Lanier, CT Albanese and A Bárcena. (2000). Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors. Exp Hematol 28:961-973.
38. McNiece IK, I Bertoncello, AB Kriegler and PJ Quesenberry. (1990). Colony-forming cells with high proliferative potential (HPP-CFC). Int J Cell Cloning 8:146-160.
39. Muench MO, M-G Roncarolo, O Rosnet, D Birnbaum and R Namikawa. (1997). Colony-forming cells expressing high levels of CD34 are the main targets for granulocyte colony-stimulating factor and macrophage colony-stimulating factor in the human fetal liver. Exp Hematol 25:277-287.
40. Lansdorp PM, W Dragowska, TE Thomas, MT Little and H Mayani. (1994). Age-related decline in proliferative po-tential of purified stem cell candidates. Blood Cells 20:376-380.
41. Murdoch B, L Gallacher, K Chadwick, F Fellows and M Bhatia. (2002). Human embryonic-derived hematopoietic repopulating cells require distinct factors to sustain in vivo repopulating function. Exp Hematol 30:598-605.
42. Muench MO, A Bárcena, T Ohkubo and MR Harrison. (1999). Requirement of retinoids for the expression of CD38 on human hematopoietic progenitors in vitro. Cytotherapy 1:455-467.
43. - progenitor cells from human cord blood generate B lymphocytes and granulocytes. Blood 89:3554-3564.
44. Roy V, JS Miller and CM Verfaillie. (1997). Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Exp Hematol 25:387-394.
45. - cells with both lymphoid and myeloid potential. Blood 91: 4145-4151.
46. Miller JS, V McCullar, M Punzel, IR Lemischka and KA Moore. (1999). Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood 93:96-106.
47. Robin C, F Pflumio, W Vainchenker and L Coulombel. (1999). Identification of lymphomyeloid primitive progenitor cells in fresh human cord blood and in the marrow of nonobese diabetic-severe combined immunodeficient (NOD-SCID) mice transplanted with human CD34(+) cord blood cells. J Exp Med 189:1601-1610.
48. ++ fetal liver cells. J Immunol 167:4902-4909.
49. Peters R, S Leyvraz, E Faes-Van't Hull, P Jaunin, S Gerber and P Rollini. (2002). Long-term ex vivo expansion of human fetal liver primitive haematopoietic progenitor cells in stroma-free cultures. Br J Haematol 119:792-802.
50. Rollini P, S Kaiser, E Faes-van't Hull, U Kapp and S Leyvraz. (2004). Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood 103:1166-1170.
51. Zanjani ED and WF Anderson. (1999). Prospects for in utero human gene therapy. Science 285:2084-2088.
52. Porada CD, P Park, G Almeida-Porada and ED Zanjani. (2004). The sheep model of in utero gene therapy. Fetal Diagn Ther 19:23-30.
53. Douar AM, M Themis and C Coutelle. (1996). Fetal somatic gene therapy. Mol Hum Reprod 2:633-641.
54. Surbek DV, W Holzgreve and KH Nicolaides. (2001). Haematopoietic stem cell transplantation and gene therapy in the fetus: ready for clinical use? Hum Reprod Update 7:85-91.
55. Haynes BF, SM Denning, KH Singer and J Kurtzberg. (1989). Ontogeny of T-cell precursors: a model for the initial stages of human T-cell development. Immunol Today 10:87-91.
56. + cells for chronic granulomatous disease. Bone Marrow Transplant 27:355-364.
57. + T-cells in the fetus. Dev Comp Immunol 27:899-914.
58. Cupedo T, M Nagasawa, K Weijer, B Blom and H Spits. (2005). Development and activation of regulatory T cells in the human fetus. Eur J Immunol 35:383-390.
59. Lipshutz GS, CA Gruber, Y Cao, J Hardy, CH Contag and KM Gaensler. (2001). In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 3:284-292.
60. Touraine JL, D Raudrant, F Golfier, A Rebaud, R Sembeil, MG Roncarolo, R Bacchetta, R D'Oiron, T Lambert and L Gebuhrer. (2004). Reappraisal of in utero stem cell transplantation based on long-term results. Fetal Diagn Ther 19:305-312.
61. Hacein-Bey-Abina S, C Von Kalle, M Schmidt, MP McCormack, N Wulffraat, P Leboulch, A Lim, CS Osborne, R Pawliuk, E Morillon, R Sorensen, A Forster, P Fraser, JI Cohen, G de Saint Basile, I Alexander, U Wintergerst, T Frebourg, A Aurias, D Stoppa-Lyonnet, S Romana, I Radford-Weiss, F Gross, F Valensi, E Delabesse, E Macintyre, F Sigaux, J Soulier, LE Leiva, M Wissler, C Prinz, TH Rabbitts, F Le Deist, A Fischer and M Cavazzana-Calvo. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419.
62. Muench MO. (2005). In utero transplantation: baby steps towards an effective therapy. Bone Marrow Transplant 35:537-547.
63. Flake AW. (2004). In utero stem cell transplantation. Best Pract Res Clin Obstet Gynaecol 18:941-958.
64. Paek BW, JB Lopoo, RW Jennings, DL Farmer, CT Albanese and MR Harrison. (2001). Safety of chronic fetal vascular access in the sheep model. Fetal Diagn Ther 16:98-100.